266 related articles for article (PubMed ID: 19666155)
1. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
Bouchez V; Brun D; Cantinelli T; Dore G; Njamkepo E; Guiso N
Vaccine; 2009 Oct; 27(43):6034-41. PubMed ID: 19666155
[TBL] [Abstract][Full Text] [Related]
2. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
3. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
4. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.
Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M
Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999
[TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
Byrne S; Slack AT
BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
[TBL] [Abstract][Full Text] [Related]
8. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
[TBL] [Abstract][Full Text] [Related]
9. Pertactin-deficient
Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim D; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; He Q
Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782265
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variation of Bordetella pertussis in Austria.
Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
12. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
13. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
Tsang RS; Sill ML; Martin IE; Jamieson F
Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
[TBL] [Abstract][Full Text] [Related]
14. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
[TBL] [Abstract][Full Text] [Related]
15. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014.
Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS
Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959
[TBL] [Abstract][Full Text] [Related]
16. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.
Komatsu E; Yamaguchi F; Abe A; Weiss AA; Watanabe M
Clin Vaccine Immunol; 2010 May; 17(5):807-12. PubMed ID: 20357056
[TBL] [Abstract][Full Text] [Related]
17. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
18. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
[TBL] [Abstract][Full Text] [Related]
19. Evolution of
Bouchez V; Guillot S; Landier A; Armatys N; Matczak S; ; Toubiana J; Brisse S
Euro Surveill; 2021 Sep; 26(37):. PubMed ID: 34533118
[TBL] [Abstract][Full Text] [Related]
20. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.
Zomer A; Otsuka N; Hiramatsu Y; Kamachi K; Nishimura N; Ozaki T; Poolman J; Geurtsen J
Microb Genom; 2018 May; 4(5):. PubMed ID: 29771235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
